| Mao, Qing |
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A |
|
|
| Completed | 3 | 750 | RoW | ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273 | Guangdong Raynovent Biotech Co., Ltd | Influenza A | 04/23 | 05/23 | | |
NCT04532229: Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children |
|
|
| Recruiting | 3 | 48 | RoW | Nimotuzumab+CRT(concurrent IMRT and TMZ), h-R3 | Biotech Pharmaceutical Co., Ltd. | Diffuse Intrinsic Pontine Glioma | 10/23 | 12/23 | | |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
| Terminated | 2/3 | 369 | Europe, RoW | BDB-001 Injection, Conventional treatment | Staidson (Beijing) Biopharmaceuticals Co., Ltd, Beijing Defengrui Biotechnology Co. Ltd | COVID-19 Pneumonia | 03/24 | 03/24 | | |
NCT04426968: A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B |
|
|
| Completed | 2 | 96 | RoW | Hepalatide 2.1mg, L47, Hepalatide 4.2mg, Hepalatide 6.3mg, placebo 2.1mg, placebo 4.2mg, placebo 6.3mg, Pegylated Interferon, Pegasys | Shanghai HEP Pharmaceutical Co., Ltd. | Hepatitis B, Chronic | 11/23 | 11/23 | | |
NCT06150014: A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B |
|
|
| Active, not recruiting | 1/2 | 88 | RoW | Placebo, TQA3605 tablets, Entecavir dispersible tablets, Tenofovir disoproxil fumarate tablet, Tenofovir alafenamide fumarate tablet | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Hepatitis b | 12/25 | 09/26 | | |
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B |
|
|
| Not yet recruiting | 1/2 | 162 | RoW | TQA3038 injection/placebo, Nucleotide drugs Control group | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatitis B, Chronic | 09/26 | 09/26 | | |
NCT06363162: Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery |
|
|
| Recruiting | N/A | 200 | RoW | Immunohistochemistry or genetic test, Raman analyzer diagnosis | Beijing Tiantan Hospital, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Capital Medical University, Jiangsu Raman Medical Equipment Co., Ltd. | Glioma | 06/25 | 12/25 | | |
NCT06525909: A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B |
|
|
| Recruiting | N/A | 250 | RoW | | Tongji Hospital | Hepatitis B, Chronic | 12/26 | 12/28 | | |
NCT05901844: Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During Surgery |
|
|
| Not yet recruiting | N/A | 256 | NA | Paraffin pathological diagnosis, Raman analyzer diagnosis | Beijing Tiantan Hospital, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Capital Medical University, Jiangsu Raman Medical Equipment Co., Ltd. | Glioma | 06/24 | 10/24 | | |
NCT06642532: A Prospective Observational Study of Transcranial Doppler Ultrasound in the Assessment of Cerebral Blood Flow After Polyetheretherketone Cranioplasty |
|
|
| Recruiting | N/A | 10 | RoW | TCD group | RenJi Hospital | Cranial Defect, TCD | 12/24 | 12/24 | | |
LPP-LPS, NCT06642129: A Prospective Observational Study of Perioperative Lumbar Puncture Pressure and Shunt Valve Pressure Management in Patients with Communicating Hydrocephalus Undergoing Lumboperitoneal Shunt Surgery |
|
|
| Recruiting | N/A | 30 | RoW | surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines | RenJi Hospital | Hydrocephalus, Communicating | 06/25 | 12/25 | | |
NCT05937178: Real-world Study Optimizing Nucleotide-analogues |
|
|
| Recruiting | N/A | 20000 | RoW | ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF | Huashan Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, Beijing YouAn Hospital, Peking University People's Hospital, Peking University First Hospital, Xiamen Hospital of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, LanZhou University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, Tongji Hospital, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, the Second Hospital of Nangjing, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital of Nanchang University, Shengjing Hospital, Qingdao Sixth People's Hospital, Shandong Provincial Hospital Affiliated to Shandong First Medical University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, West China Hospital, Tianjin Second People's Hospital, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Yunnan, Shulan (Hangzhou) Hospital, Zhejiang University, Southwest Hospital, China, The Second Affiliated Hospital of Chongqing Medical University, Sichuan Provincial People's Hospital | Hepatitis B, Chronic | 01/29 | 01/29 | | |
| Zhang, Leida |
| Active, not recruiting | 3 | 408 | RoW | KN046, placebo | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Pancreatic Ductal Adenocarcinoma | 04/24 | 08/24 | | |
NCT06310590: Safety and Efficacy of NRT6003 in Patients With Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | 1 | 40 | RoW | NRT6003 Injection, Yttrium-90 carbon microspheres | Chengdu New Radiomedicine Technology Co. LTD. | Unresectable Hepatocellular Carcinoma | 10/25 | 10/25 | | |
NCT02515474: Comparison of LCBDE vs ERCP + LC for Choledocholithiasis |
|
|
| Completed | N/A | 1000 | RoW | Laparoscopy, Laparoscopic common bile duct exploration (LCBDE), Endoscopy, Endoscopic Retrograde cholangiopancreatography (ERCP) | Hepatopancreatobiliary Surgery Institute of Gansu Province | Choledocholithiasis | 01/24 | 01/24 | | |
| Recruiting | N/A | 200 | RoW | Hematoporphyrin, ERCP stents | Hepatopancreatobiliary Surgery Institute of Gansu Province | Cholangiocarcinoma Non-resectable | 05/24 | 05/24 | | |
| Wang, Bin S |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
ACHIEVE, NCT04808752: Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases |
|
|
| Active, not recruiting | 2 | 63 | RoW | Almonertinib, Investigational Product | Zhejiang Cancer Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Lung Cancer | 06/24 | 07/24 | | |
NCT06006689: Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) |
|
|
| Recruiting | 2 | 228 | RoW | Qishen Yiqi Dripping Pills placebo 3 bags, Placebo group, Low dose Qishen Yiqi Dripping Pills 3 bags, Low dose group, High dose Qishen Yiqi Dripping Pills 3 bags, High dose group | Tasly Pharmaceutical Group Co., Ltd | Diabetic Kidney Disease | 09/25 | 09/25 | | |
NCT04172168: Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI) |
|
|
| Recruiting | N/A | 17568 | RoW | Heart rupture | Xiamen Cardiovascular Hospital, Xiamen University | Acute Myocardial Infarction | 12/19 | 03/21 | | |
NCT04475978: Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients：a Prospective, Multicenter, Randomized Controlled Trial |
|
|
| Recruiting | N/A | 208 | RoW | IVUS-guide DCB PTCA, Angio-guide DCB PTCA | Xiamen Cardiovascular Hospital, Xiamen University | STEMI | 01/23 | 03/23 | | |
NCT05703191: A Real-world Study of Nitric Oxide Generator and Delivery System |
|
|
| Recruiting | N/A | 10 | RoW | Nitric Oxide Generator and Delivery System | Novlead Inc. | Pulmonary Hypertension of Newborn | 03/23 | 05/23 | | |
NCT05459714: Magnetically Controlled Capsule Endoscope System in Stomach Examination of Moderately and Severely Obese Patients |
|
|
| Not yet recruiting | N/A | 30 | RoW | MCE for obese patients | Changhai Hospital, Shanghai 6th People's Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Obesity | 05/23 | 05/23 | | |
NCT06358118: Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders |
|
|
| Not yet recruiting | N/A | 240 | RoW | Buyuan Zhixiao Formula, Placebo | Qing Ni | Diabete Mellitus, Aging, Metabolic Disorders, Traditional Chinese Medicine, Randomized Controlled Trial | 07/25 | 07/25 | | |
NCT05862103: Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort |
|
|
| Recruiting | N/A | 15000 | RoW | Treatment Strategies | Yu Bo | Acute Myocardial Infarction, Adverse Event | 08/25 | 12/26 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Recruiting | N/A | 1332 | RoW | The lying flat (0°-10°) head position for 72 hours, The The head elevation (30°-40°) position for 72 hours | Zhengzhou Yuan | Stroke, Acute, Endovascular Therapy | 11/25 | 04/26 | | |
| Jin, Jun |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT06051513: Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection |
|
|
| Recruiting | N/A | 360 | RoW | treatment with or without colistin | Southeast University, China | Carbapenem-Resistant Enterobacteriaceae Infection | 07/25 | 11/25 | | |
| Wei, Yanling |
NCT04890405: Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome. |
|
|
| Not yet recruiting | N/A | 70 | NA | Standardized FMT, Precision Flora Transplantation | Yanling Wei | Irritable Bowel Syndrome Variant of Childhood | 10/21 | 10/22 | | |
NCT05427331: FMT Capsules in Treatment of Patients With Insomnia Clinical Research |
|
|
| Recruiting | N/A | 60 | RoW | FMT capsule | Third Military Medical University | Chronic Insomnia | 05/23 | 12/23 | | |
NCT06419530: A Study on Probiotic Formula in Autistic Children |
|
|
| Not yet recruiting | N/A | 156 | RoW | Probiotic formula capsule, placebo capsule, FMT capsule | Third Military Medical University | Autism Spectrum Disorder | 06/27 | 06/28 | | |
NCT05043818: A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression |
|
|
| Not yet recruiting | N/A | 178 | RoW | | Third Military Medical University | Inflammatory Bowel Diseases | 09/22 | 09/22 | | |
NCT05336773: Ulcerative Colitis Mayo Score With Artificial Intelligence |
|
|
| Not yet recruiting | N/A | 500 | RoW | | Third Military Medical University | Ulcerative Colitis, Colonoscopy, Deep Learning | 12/22 | 06/23 | | |
NCT05694481: An Observational Clinical Study on the Intestinal Flora in Circadian Rhythm Disorder and Healthy Controls |
|
|
| Not yet recruiting | N/A | 80 | RoW | | Third Military Medical University | Circadian Rhythm Disorders, Intestinal Flora | 03/23 | 03/23 | | |
